1. Fleming TR: Current issues in non-inferiority trials. Stat Med. 2008, 27: 317-322. 10.1002/sim.2855.
2. D’Agostinio RB: Non-inferiority trials: advances in concepts and methodology. Stat Med. 2003, 22: 165-167.
3. Jones B, Jarvis P, Lewis JA, Ebbutt AF: Trials to assess equivalence: the importance of rigorous methods. BMJ. 1996, 313: 36-39. 10.1136/bmj.313.7048.36.
4. ICH Steering Committee: Statistical Principles for Clinical Trials (E9). 1998, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, Geneva, Switzerland, http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E9/Step4/E9_Guideline.pdf ,
5. US Food and Drug Administration: Guidance for Industry Non-Inferiority Clinical Trials. US Department of Health and human Services; 2010; available at, Rockville, USA, http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM202140.pdf ,